Year: 2014
Type: article
Abstract: Atherosclerosis is associated with chronic inflammation occurring over decades. The enzyme 15-lipoxygenase-2 (15-LOX-2) is highly expressed in large atherosclerotic plaques, and its activity has been linked to the progression of macrophages to the lipid-laden foam cells present in atherosclerotic plaques. We report here the crystal structure of human 15-LOX-2 in complex with an inhibitor that appears to bind as a substrate mimic. 15-LOX-2 contains a long loop, composed of hydrophobic amino acids, which projects from the amino-terminal membrane-binding domain. The loop is flanked by two Ca(2+)-binding sites that confer Ca(2+)-dependent membrane binding. A comparison of the human 15-LOX-2 and 5-LOX structures reveals similarities at the active sites, as well striking differences that can be exploited for design of isoform-selective inhibitors.
Source: Journal of Biological Chemistry
Institutions: Louisiana State University, Argonne National Laboratory
Language: English
Subfield: Structural Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,430
Awards: G102163711, G107546177, G1505794299, G1664757510, Louisiana State University Science, Technology, Engineering, and Mathematics Research Scholars Program (LA-STEM) -- Phase II, G2101401529, G2287611682, G262962599, G2887060908, G3075337988, G340565428, G5106849484, G6848031779, G6918803902, G7368700025, The Structural Basis for Control of 5-Lipoxgenease Activity, NE-CAT Center for Advanced Macromolecular Crystallography, G8987127993, G993149817
OpenAlex ID: W2076699828
